ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Cerminara S, Cvijetic I, Huber S, Mueller S, Kostner L, Goessinger E, Narainsing J, Dutilh G, Heidemeyer K, Yawalkar N, Conrad C, Plaza T, Maul J, Cozzio A, Navarini A. ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis. J Eur Acad Dermatol Venereol 2024
Oct 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Oct 24, 2024
J Eur Acad Dermatol Venereol 2024
Cerminara Sara Elisa, Cvijetic Ivana, Huber Stephanie, Mueller Simon M, Kostner Lisa, Goessinger Elisabeth V, Narainsing Jasmin, Dutilh Gilles, Heidemeyer Kristine, Yawalkar Nikhil, Conrad Curdin, Plaza Tobias, Maul Julia-Tatjana, Cozzio Antonio, Navarini Alexander A
more